Warning: The NCBI web site requires JavaScript to function. more...
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.
Breast Cancer Res. 2006;8(5):R56.
Related citations
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.
Smalley MJ, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan JL, Britt K, McDonald S, Lord CJ, Mackay A, Ashworth A.
Breast Cancer Res. 2007;9(6):R85.
Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.
Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L, Dexter T, Davies S, Bulmer K, Ford E, Parry S, Budroni M, Palmieri G, Neville AM, O'Hare MJ, Lakhani SR.
Cancer Res. 2004 May 1;64(9):3037-45.
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.
Breast Cancer Res. 2007;9(5):R59.
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.
BMC Genomics. 2006 May 26;7:127.
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.
Breast Cancer Res. 2009;11(1):R1. Epub 2009 Jan 5.
Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate.
Kendrick H, Regan JL, Magnay FA, Grigoriadis A, Mitsopoulos C, Zvelebil M, Smalley MJ.
BMC Genomics. 2008 Dec 8;9:591.
Identification of differentially expressed sense and antisense transcript pairs in breast epithelial tissues.
Grigoriadis A, Oliver GR, Tanney A, Kendrick H, Smalley MJ, Jat P, Neville AM.
BMC Genomics. 2009 Jul 17;10:324.
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.
PLoS One. 2009 Jul 3;4(7):e6146.
Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.
Gene. 2011 Dec 10;489(2):63-9. Epub 2011 Sep 2.
In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
Cha S, Imielinski MB, Rejtar T, Richardson EA, Thakur D, Sgroi DC, Karger BL.
Mol Cell Proteomics. 2010 Nov;9(11):2529-44. Epub 2010 Aug 25.
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO.
Int J Cancer. 2005 Sep 1;116(3):340-50.
Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
Smith DD, Saetrom P, Snøve O Jr, Lundberg C, Rivas GE, Glackin C, Larson GP.
BMC Bioinformatics. 2008 Jan 28;9:63.
Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.
Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.
Cancer Res. 2004 Feb 1;64(3):844-56.
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger R.
BMC Cancer. 2010 Dec 3;10:666.
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C, Benz CC.
Breast Cancer Res. 2008;10(4):R61. Epub 2008 Jul 17.
Transcription profiles of non-immortalized breast cancer cell lines.
Fernandez-Cobo M, Holland JF, Pogo BG.
BMC Cancer. 2006 Apr 20;6:99.
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL.
J Pathol. 2008 Feb;214(3):357-67.
Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation.
Westbury CB, Reis-Filho JS, Dexter T, Mahler-Araujo B, Fenwick K, Iravani M, Grigoriadis A, Parry S, Robertson D, Mackay A, Ashworth A, Yarnold JR, Isacke CM.
J Pathol. 2009 Sep;219(1):131-40.
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.
J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on